Anita P. Price

Pulmonary Outcome at 1 Year Corrected Age in Premature Infants Treated at Birth With Recombinant Human CuZn Superoxide Dismutase

Jonathan M. Davis, Richard B. Parad, Theresa M. Michele et al. · PEDIATRICS · 2003 · 268 citations

Medicine, Child Health, Pediatrics +17

Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience

Denise A. Casey, Leonard H. Wexler, Melinda S. Merchant et al. · Pediatric Blood & Cancer · 2009 · 193 citations

Medicine, Oncology, Pharmacology +16

Safety and Pharmacokinetics of Multiple Doses of Recombinant Human CuZn Superoxide Dismutase Administered Intratracheally to Premature Neonates With Respiratory Distress Syndrome

Jonathan M. Davis, Warren Rosenfeld, Susan E. Richter et al. · PEDIATRICS · 1997 · 130 citations

Medicine, Pediatrics, Pharmacology +17

Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors

Melinda S. Merchant, James I. Geller, Kristin Baird et al. · Journal of Clinical Oncology · 2012 · 111 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety and Pharmacokinetics of Recombinant Human Superoxide Dismutase Administered Intratracheally to Premature Neonates With Respiratory Distress Syndrome

Warren Rosenfeld, Jonathan M. Davis, Lance A. Parton et al. · PEDIATRICS · 1996 · 84 citations

Medicine, Pharmacokinetics, Pharmacology +17